INS and Hypoglycemia: At least one overall confirmed case of hypoglycemia was reported in 728 of 1129 (64.5%) participants who were administered with twice-daily IDegAsp in six RCTs [15,16,17,18,19,20], and 541 of 1269 (67.6%) participants who were administered with conventional premixed insulin.